Australia
bet9¹ÙÍø Australia has a vast pipeline of products that are supplied in Australia as well as US & EU. Millions of Australians have access to a bet9¹ÙÍø manufactured product through our community pharmacy partners around Australia.
Our state-of-the-art manufacturing facilities are TGA approved as well as being USFDA (USA) and MHRA (UK) approved. bet9¹ÙÍø Australia has over 200 registeredÌýformulationsÌýwith TGA through partnerships with market leaders and on its own. The list of registered medicines includes OTC (Over the Counter), Prescription and hospital medicines. We are also involved in helping Australians access medicines through the SAS (Special Access Scheme). bet9¹ÙÍø has earned a name for maintaining world-class quality across all our manufacturing units, products and services. Globally, our patent filing includes drug substances, drug products, platform technologies, IP on polymorphs and crystallinity, and medical devices.
Quick Facts
Australian Presence
2000
Employees
30+
Product Registrations
500+
bet9¹ÙÍø Deferasirox Educational materials
bet9¹ÙÍø Ambrisentan Educational materials
bet9¹ÙÍø Adalimumab Educational materials
bet9¹ÙÍø Lenalidomide Educational materials
-
bet9¹ÙÍø Lenalidomide Information Brochure for HCP
-
bet9¹ÙÍø Lenalidomide Patient Brochure
-
bet9¹ÙÍø Lenalidomide Patient card
-
bet9¹ÙÍø Lenalidomide Initiation Checklist - Combined
-
bet9¹ÙÍø Lenalidomide Treatment Initiation Form-Male Patients
-
bet9¹ÙÍø Lenalidomide Treatment Initiation Form-Women of Child bearing Potential
-
bet9¹ÙÍø Lenalidomide Treatment Initiation Form - Women of Non-Child bearing Potential
-
bet9¹ÙÍø Lenalidomide Pharmacy Registration Form
-
bet9¹ÙÍø Lenalidomide Prescription Authorisation Form
-
bet9¹ÙÍø Lenalidomide Adverse Event Form
-
bet9¹ÙÍø Lenalidomide Pregnancy Outcome Form
-
bet9¹ÙÍø Lenalidomide Pregnancy Reporting Form
-
bet9¹ÙÍø Lenalidomide caregiver guide
bet9¹ÙÍø Fingolimod Educational materials
bet9¹ÙÍø Australia Pty Ltd,Ìý
Level 1, 132 - 136 Albert Road,
South Melbourne, VIC 3205
Phone : +613 9696 4438
Drug Safety Reporting in Australia
1800-569-074
Phone: +91 821-6643551 (Except US and EU)
Email : drugsafety@cipla.com
Office, HR and Operations enquiries
Ragda Harmouche
Ragda.harmouche@cipla.com
bet9¹ÙÍø has a long heritage of being a world leader in Respiratory Therapy - India, South Africa and various Emerging Markets to name a few. In keeping with our purpose of ‘Caring for Life’, we are constantly working towards improving patient access to necessary and innovative medicines for better management of diseases and improved quality of life. We pride ourselves in having the world’s largest respiratory range of drugs, dosage forms and devices for COPD and Asthma. Our products are available in more than 80+ countries worldwide. Key products were successfully launched in many European countries e.g. UK, Germany, Belgium, Netherlands, Czech Republic and Croatia.
